Tyrosinemia Type 1 Should Be Suspected in Infants With Severe Coagulopathy Even in the Absence of Other Signs of Liver Failure

Tyrosinemia type l is an inherited metabolic disorder attributable to deficiency of fumarylacetoacetate hydrolase, a terminal enzyme in the degradation pathway of tyrosine. Affected individuals may present with any of a number of signs and symptoms, including failure to thrive, fever, vomiting, diar...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatrics (Evanston) 1999-03, Vol.103 (3), p.675-678
Hauptverfasser: Croffie, Joseph M, Gupta, Sandeep K, Chong, Sonny K. F, Fitzgerald, Joseph F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 678
container_issue 3
container_start_page 675
container_title Pediatrics (Evanston)
container_volume 103
creator Croffie, Joseph M
Gupta, Sandeep K
Chong, Sonny K. F
Fitzgerald, Joseph F
description Tyrosinemia type l is an inherited metabolic disorder attributable to deficiency of fumarylacetoacetate hydrolase, a terminal enzyme in the degradation pathway of tyrosine. Affected individuals may present with any of a number of signs and symptoms, including failure to thrive, fever, vomiting, diarrhea, hepatomegaly, ascites, jaundice, renal Fanconi syndrome, or conditions such as rickets and hepatocellular carcinoma.1 If untreated, the patient may die of acute liver failure before the second year of life, or from chronic liver failure or hepatocellular carcinoma before the end of the second decade of life.2 Although overt liver failure with coagulopathy may be part of the presentation of tyrosinemia, a significant coagulopathy in the absence of overt signs of liver disease has not been emphasized as a clue to the diagnosis of this condition. We report two tyrosinemic infants who presented with severe coagulopathies and no other signs of liver failure to stress this diagnostic point.
doi_str_mv 10.1542/peds.103.3.675
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_69599015</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A54128100</galeid><sourcerecordid>A54128100</sourcerecordid><originalsourceid>FETCH-LOGICAL-c560t-f84aa86c8ef43e9be0b06b9295dd80fc0de900a4049372d13476c918336d6a6c3</originalsourceid><addsrcrecordid>eNpt0s2O0zAQAOAIgdhl4coRWQghDpsyjvN7LNXuslKlHlrE0XKdSeJVagfbWeiJV-FZeDJctVK3qMrBHuuzx55MFL2lMKFZmnwesHYTCmzCJnmRPYsuKVRlnCZF9jy6BGA0TgGyi-iVcw8AkGZF8jK6oGFWVUV5Gf1eba1xSuNGCbLaDkjo3z_Lzox9Tb4gWY5uQOmxJkqTe90I7R35rnxHlviIFsnMiHbszSB8tyU3j6h30HdIpmuHWiIxDVmE2JKlarXbhXMVdpJbofrR4uvoRSN6h28O41X07fZmNfsazxd397PpPJZZDj5uylSIMpclNinDao2whnxdJVVW1yU0EmqsAEQansWKpKYsLXJZ0ZKxvM5FLtlV9HF_7mDNjxGd5xvlJPa90GhGx_MqqyqgWYDv_4MPZrQ63I0nSZlCxoAGdL1HreiRK90Yb4VsUaMVvdHYqLA8zVKalKHUgcdnePjqUHZ5zn868YF4_OVbMTrHy7v5Cb0-R6Xpe2yRhxrOFid8sucy_HVnseGDVRtht5wC3zUU3zVUCBhnPDRU2PDuUI5xvcH6Cd93UAAfDkA4KfrGCi2VO7qClkDTY-JOtd1PZXGXSAlvlXRPpsfE_wAdt-GQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>228405301</pqid></control><display><type>article</type><title>Tyrosinemia Type 1 Should Be Suspected in Infants With Severe Coagulopathy Even in the Absence of Other Signs of Liver Failure</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Croffie, Joseph M ; Gupta, Sandeep K ; Chong, Sonny K. F ; Fitzgerald, Joseph F</creator><creatorcontrib>Croffie, Joseph M ; Gupta, Sandeep K ; Chong, Sonny K. F ; Fitzgerald, Joseph F</creatorcontrib><description>Tyrosinemia type l is an inherited metabolic disorder attributable to deficiency of fumarylacetoacetate hydrolase, a terminal enzyme in the degradation pathway of tyrosine. Affected individuals may present with any of a number of signs and symptoms, including failure to thrive, fever, vomiting, diarrhea, hepatomegaly, ascites, jaundice, renal Fanconi syndrome, or conditions such as rickets and hepatocellular carcinoma.1 If untreated, the patient may die of acute liver failure before the second year of life, or from chronic liver failure or hepatocellular carcinoma before the end of the second decade of life.2 Although overt liver failure with coagulopathy may be part of the presentation of tyrosinemia, a significant coagulopathy in the absence of overt signs of liver disease has not been emphasized as a clue to the diagnosis of this condition. We report two tyrosinemic infants who presented with severe coagulopathies and no other signs of liver failure to stress this diagnostic point.</description><identifier>ISSN: 0031-4005</identifier><identifier>EISSN: 1098-4275</identifier><identifier>DOI: 10.1542/peds.103.3.675</identifier><identifier>PMID: 10049978</identifier><identifier>CODEN: PEDIAU</identifier><language>eng</language><publisher>Elk Grove Village, IL: Am Acad Pediatrics</publisher><subject>Amino Acid Metabolism, Inborn Errors - complications ; Amino Acid Metabolism, Inborn Errors - diagnosis ; Aminoacid disorders ; Babies ; Biological and medical sciences ; Birth defects ; Bleeding ; Blood Coagulation Disorders - complications ; Causes of ; Diagnosis ; Enzymes ; Errors of metabolism ; Female ; Humans ; Infant ; Liver ; Liver diseases ; Liver Failure - complications ; Liver Failure - surgery ; Liver Transplantation ; Male ; Medical disorders ; Medical sciences ; Metabolic diseases ; Metabolism ; Pediatrics ; Physiological aspects ; Proteins ; Transplantation ; Tyrosine - blood ; Tyrosine metabolism</subject><ispartof>Pediatrics (Evanston), 1999-03, Vol.103 (3), p.675-678</ispartof><rights>1999 INIST-CNRS</rights><rights>COPYRIGHT 1999 American Academy of Pediatrics</rights><rights>COPYRIGHT 1999 American Academy of Pediatrics</rights><rights>Copyright American Academy of Pediatrics Mar 1999</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c560t-f84aa86c8ef43e9be0b06b9295dd80fc0de900a4049372d13476c918336d6a6c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1718014$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10049978$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Croffie, Joseph M</creatorcontrib><creatorcontrib>Gupta, Sandeep K</creatorcontrib><creatorcontrib>Chong, Sonny K. F</creatorcontrib><creatorcontrib>Fitzgerald, Joseph F</creatorcontrib><title>Tyrosinemia Type 1 Should Be Suspected in Infants With Severe Coagulopathy Even in the Absence of Other Signs of Liver Failure</title><title>Pediatrics (Evanston)</title><addtitle>Pediatrics</addtitle><description>Tyrosinemia type l is an inherited metabolic disorder attributable to deficiency of fumarylacetoacetate hydrolase, a terminal enzyme in the degradation pathway of tyrosine. Affected individuals may present with any of a number of signs and symptoms, including failure to thrive, fever, vomiting, diarrhea, hepatomegaly, ascites, jaundice, renal Fanconi syndrome, or conditions such as rickets and hepatocellular carcinoma.1 If untreated, the patient may die of acute liver failure before the second year of life, or from chronic liver failure or hepatocellular carcinoma before the end of the second decade of life.2 Although overt liver failure with coagulopathy may be part of the presentation of tyrosinemia, a significant coagulopathy in the absence of overt signs of liver disease has not been emphasized as a clue to the diagnosis of this condition. We report two tyrosinemic infants who presented with severe coagulopathies and no other signs of liver failure to stress this diagnostic point.</description><subject>Amino Acid Metabolism, Inborn Errors - complications</subject><subject>Amino Acid Metabolism, Inborn Errors - diagnosis</subject><subject>Aminoacid disorders</subject><subject>Babies</subject><subject>Biological and medical sciences</subject><subject>Birth defects</subject><subject>Bleeding</subject><subject>Blood Coagulation Disorders - complications</subject><subject>Causes of</subject><subject>Diagnosis</subject><subject>Enzymes</subject><subject>Errors of metabolism</subject><subject>Female</subject><subject>Humans</subject><subject>Infant</subject><subject>Liver</subject><subject>Liver diseases</subject><subject>Liver Failure - complications</subject><subject>Liver Failure - surgery</subject><subject>Liver Transplantation</subject><subject>Male</subject><subject>Medical disorders</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Metabolism</subject><subject>Pediatrics</subject><subject>Physiological aspects</subject><subject>Proteins</subject><subject>Transplantation</subject><subject>Tyrosine - blood</subject><subject>Tyrosine metabolism</subject><issn>0031-4005</issn><issn>1098-4275</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0s2O0zAQAOAIgdhl4coRWQghDpsyjvN7LNXuslKlHlrE0XKdSeJVagfbWeiJV-FZeDJctVK3qMrBHuuzx55MFL2lMKFZmnwesHYTCmzCJnmRPYsuKVRlnCZF9jy6BGA0TgGyi-iVcw8AkGZF8jK6oGFWVUV5Gf1eba1xSuNGCbLaDkjo3z_Lzox9Tb4gWY5uQOmxJkqTe90I7R35rnxHlviIFsnMiHbszSB8tyU3j6h30HdIpmuHWiIxDVmE2JKlarXbhXMVdpJbofrR4uvoRSN6h28O41X07fZmNfsazxd397PpPJZZDj5uylSIMpclNinDao2whnxdJVVW1yU0EmqsAEQansWKpKYsLXJZ0ZKxvM5FLtlV9HF_7mDNjxGd5xvlJPa90GhGx_MqqyqgWYDv_4MPZrQ63I0nSZlCxoAGdL1HreiRK90Yb4VsUaMVvdHYqLA8zVKalKHUgcdnePjqUHZ5zn868YF4_OVbMTrHy7v5Cb0-R6Xpe2yRhxrOFid8sucy_HVnseGDVRtht5wC3zUU3zVUCBhnPDRU2PDuUI5xvcH6Cd93UAAfDkA4KfrGCi2VO7qClkDTY-JOtd1PZXGXSAlvlXRPpsfE_wAdt-GQ</recordid><startdate>19990301</startdate><enddate>19990301</enddate><creator>Croffie, Joseph M</creator><creator>Gupta, Sandeep K</creator><creator>Chong, Sonny K. F</creator><creator>Fitzgerald, Joseph F</creator><general>Am Acad Pediatrics</general><general>American Academy of Pediatrics</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8GL</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>U9A</scope><scope>7X8</scope></search><sort><creationdate>19990301</creationdate><title>Tyrosinemia Type 1 Should Be Suspected in Infants With Severe Coagulopathy Even in the Absence of Other Signs of Liver Failure</title><author>Croffie, Joseph M ; Gupta, Sandeep K ; Chong, Sonny K. F ; Fitzgerald, Joseph F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c560t-f84aa86c8ef43e9be0b06b9295dd80fc0de900a4049372d13476c918336d6a6c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Amino Acid Metabolism, Inborn Errors - complications</topic><topic>Amino Acid Metabolism, Inborn Errors - diagnosis</topic><topic>Aminoacid disorders</topic><topic>Babies</topic><topic>Biological and medical sciences</topic><topic>Birth defects</topic><topic>Bleeding</topic><topic>Blood Coagulation Disorders - complications</topic><topic>Causes of</topic><topic>Diagnosis</topic><topic>Enzymes</topic><topic>Errors of metabolism</topic><topic>Female</topic><topic>Humans</topic><topic>Infant</topic><topic>Liver</topic><topic>Liver diseases</topic><topic>Liver Failure - complications</topic><topic>Liver Failure - surgery</topic><topic>Liver Transplantation</topic><topic>Male</topic><topic>Medical disorders</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Metabolism</topic><topic>Pediatrics</topic><topic>Physiological aspects</topic><topic>Proteins</topic><topic>Transplantation</topic><topic>Tyrosine - blood</topic><topic>Tyrosine metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Croffie, Joseph M</creatorcontrib><creatorcontrib>Gupta, Sandeep K</creatorcontrib><creatorcontrib>Chong, Sonny K. F</creatorcontrib><creatorcontrib>Fitzgerald, Joseph F</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: High School</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatrics (Evanston)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Croffie, Joseph M</au><au>Gupta, Sandeep K</au><au>Chong, Sonny K. F</au><au>Fitzgerald, Joseph F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tyrosinemia Type 1 Should Be Suspected in Infants With Severe Coagulopathy Even in the Absence of Other Signs of Liver Failure</atitle><jtitle>Pediatrics (Evanston)</jtitle><addtitle>Pediatrics</addtitle><date>1999-03-01</date><risdate>1999</risdate><volume>103</volume><issue>3</issue><spage>675</spage><epage>678</epage><pages>675-678</pages><issn>0031-4005</issn><eissn>1098-4275</eissn><coden>PEDIAU</coden><abstract>Tyrosinemia type l is an inherited metabolic disorder attributable to deficiency of fumarylacetoacetate hydrolase, a terminal enzyme in the degradation pathway of tyrosine. Affected individuals may present with any of a number of signs and symptoms, including failure to thrive, fever, vomiting, diarrhea, hepatomegaly, ascites, jaundice, renal Fanconi syndrome, or conditions such as rickets and hepatocellular carcinoma.1 If untreated, the patient may die of acute liver failure before the second year of life, or from chronic liver failure or hepatocellular carcinoma before the end of the second decade of life.2 Although overt liver failure with coagulopathy may be part of the presentation of tyrosinemia, a significant coagulopathy in the absence of overt signs of liver disease has not been emphasized as a clue to the diagnosis of this condition. We report two tyrosinemic infants who presented with severe coagulopathies and no other signs of liver failure to stress this diagnostic point.</abstract><cop>Elk Grove Village, IL</cop><pub>Am Acad Pediatrics</pub><pmid>10049978</pmid><doi>10.1542/peds.103.3.675</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0031-4005
ispartof Pediatrics (Evanston), 1999-03, Vol.103 (3), p.675-678
issn 0031-4005
1098-4275
language eng
recordid cdi_proquest_miscellaneous_69599015
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Amino Acid Metabolism, Inborn Errors - complications
Amino Acid Metabolism, Inborn Errors - diagnosis
Aminoacid disorders
Babies
Biological and medical sciences
Birth defects
Bleeding
Blood Coagulation Disorders - complications
Causes of
Diagnosis
Enzymes
Errors of metabolism
Female
Humans
Infant
Liver
Liver diseases
Liver Failure - complications
Liver Failure - surgery
Liver Transplantation
Male
Medical disorders
Medical sciences
Metabolic diseases
Metabolism
Pediatrics
Physiological aspects
Proteins
Transplantation
Tyrosine - blood
Tyrosine metabolism
title Tyrosinemia Type 1 Should Be Suspected in Infants With Severe Coagulopathy Even in the Absence of Other Signs of Liver Failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T16%3A17%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tyrosinemia%20Type%201%C2%A0Should%20Be%20Suspected%20in%20Infants%20With%20Severe%20Coagulopathy%20Even%20in%20the%20Absence%20of%20Other%20Signs%20of%20Liver%20Failure&rft.jtitle=Pediatrics%20(Evanston)&rft.au=Croffie,%20Joseph%20M&rft.date=1999-03-01&rft.volume=103&rft.issue=3&rft.spage=675&rft.epage=678&rft.pages=675-678&rft.issn=0031-4005&rft.eissn=1098-4275&rft.coden=PEDIAU&rft_id=info:doi/10.1542/peds.103.3.675&rft_dat=%3Cgale_proqu%3EA54128100%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=228405301&rft_id=info:pmid/10049978&rft_galeid=A54128100&rfr_iscdi=true